Picture of YARROW BIOSCIENCE logo

YARW — YARROW BIOSCIENCE News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: VYNE Therapeutics Q3 Basic EPS USD -0.29

Nov 07 (Reuters) - VYNE Therapeutics Q3 EPS from cont ops USD -0.29.
* Q3 revenue USD 121 thousand
* Q3 net income USD -12.157 million

Recent news on YARROW BIOSCIENCE

See all news